Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143588 |
| CAS No | 64605-07-8 |
| Mol.F. | C6H12N2O2 |
| Mol.Wt. | 144.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143589 |
| CAS No | 96724-44-6 |
| Mol.F. | C5H11N3O3 |
| Mol.Wt. | 161.2g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143590 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143591 |
| CAS No | NA |
| Mol.F. | C12H18N2O3 |
| Mol.Wt. | 238.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143592 |
| CAS No | NA |
| Mol.F. | C28H32N4O3 |
| Mol.Wt. | 472.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143593 |
| CAS No | NA |
| Mol.F. | C24H32N4O5 |
| Mol.Wt. | 456.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143594 |
| CAS No | NA |
| Mol.F. | C10H20N2O8 |
| Mol.Wt. | 296.3 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143595 |
| CAS No | 854234-69-8 |
| Mol.F. | C13H12N2O |
| Mol.Wt. | 212.25 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143596 |
| CAS No | NA |
| Mol.F. | C5H11ClN2O |
| Mol.Wt. | 150.6 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143597 |
| CAS No | NA |
| Mol.F. | C5H12N2O2 |
| Mol.Wt. | 132.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143598 |
| CAS No | NA |
| Mol.F. | C20H18N6O3 |
| Mol.Wt. | 390.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143599 |
| CAS No | NA |
| Mol.F. | C21H36N2O3 |
| Mol.Wt. | 364.5g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143600 |
| CAS No | NA |
| Mol.F. | C13H16N6O3 |
| Mol.Wt. | 304.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143601 |
| CAS No | NA |
| Mol.F. | C18H28N2O6 |
| Mol.Wt. | 368.4 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143602 |
| CAS No | NA |
| Mol.F. | C11H18N4O6S3 |
| Mol.Wt. | 398.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143603 |
| CAS No | NA |
| Mol.F. | C8H7D6N3OS |
| Mol.Wt. | 205.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |